BMO 'Neutral to Positive' on Pfizer's (PFE) Medivation Takeover
Tweet Send to a Friend
BMO Capital analyst Alex Arfaei weighed in on Pfizer's (NYSE: PFE) $14 billion takeover of Medivation (NASDAQ: MDVN), saying he ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
